$INSY Looks like trading is still on hold for this
$INSY Looks like trading is still on hold for this stock.
MY OPINION: The share price closed in the toilet and appears that the share price may not move upwards for a while. The charges against the (former) CEO are significant. The GOOD NEWS for him is that he has the financial resources to hire the best lawyers in the US to fight the charges. The BAD NEWS for INSY investors is that as long as his name is in the News, the company image, and its stock, may continue to take a beating.
If/when INSY trading returns this week, it remains to be seen if there is any confidence by investors that this stock will return to the $10.00+/share price over the next several weeks. One can hope that, when trading returns, investors do see long term profit in the company and the share price starts an incremental climb back up to the $10/level. Wishful thinking? Perhaps.
The current company Executive Management is taking control of the situation and is acknowledging the past mistakes and taking corrective action to prevent the mistakes from being repeated. This action alone should provide investors with a much higher degree of confidence and interest than had the company done nothing. There will continue to be Bad Press due to the (former) CEO's failure to control the sales processes. He will still represent the IMAGE of INSY until the current Executive Management convinces the Media that the company will be completely ethical in its business dealings and the Current Executive Management is 100% in control of the direction of the company.
Insys Therapeutics Inc. (INSYQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...
Continue Reading
A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...
Continue Reading
New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...
Continue Reading
Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...
Continue Reading
Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...
Continue Reading
Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...
Continue Reading
Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...
Continue Reading
Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...
Continue Reading
Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...
Continue Reading
Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...
Continue Reading
Top 5 Most Recently Viewed Articles
Bouygues Boosts Shareholder Value with Buyback Initiatives In corporate finance, share buybacks are often adopted as a strategic way to strengthen shareholder trust and increase stock value. Recently, Bouygues SA's trading activities have shown their dedication to creating value and aligning with the interests of their shareholders. Summary of Recent Buyback Activities...
Continue Reading
Warren Buffett's Investment Challenges with Occidental Petroleum Recently, Occidental Petroleum's shares dropped by 29% since mid-April, which has a direct impact on Warren Buffett’s large investment in the company. This decline raises concerns about potential strategies for future investments. Investment Context and Current Situation Chris Bloomstran, an experienced...
Continue Reading
Enhancing Audio Experience with Datavault AI's Innovations In the ever-evolving world of audio technology, Datavault AI has made significant strides to enhance the home audio experience. Through its Acoustic Science Division's Wireless Sound Association (WiSA), the company has launched several cutting-edge solutions designed to elevate audio quality while maintaining...
Continue Reading
Turkey's Central Bank Interest Rate Adjustment The central bank of Turkey has recently made headlines by announcing a significant reduction in its interest rate for the second consecutive time. This move is primarily attributed to a more pronounced slowdown in inflation that has taken place recently. Rate Cut Details The Monetary Policy Committee, led by the governor, has...
Continue Reading
Embracing Inclusivity: The Proud Pair Jewelry Initiative In a significant step towards inclusivity, Hong Kong Marriage Equality has joined forces with the innovative local jewellery brand Playback Concept to unveil the "Proud Pair" collection. This unique initiative reimagines traditional jewellery by incorporating essential motifs that resonate with diverse gender...
Continue Reading